Authors
Loading...
Review uncovers redox-driven beta cell death mechanisms in diabetes, highlighting the therapeutic potential of antioxidants and CRISPR/Cas9 epigenome editing.
Dinić et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: